Manufacturing Integration Technology Ltd (SGX:M11)

Market Cap	5.30M
Revenue (ttm)	8.51M
Net Income (ttm)	-3.02M
Shares Out	241.11M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	49,825
Open	0.0220
Previous Close	0.0220
Day's Range	0.0220 - 0.0220
52-Week Range	0.0110 - 0.0330
Beta	0.20
RSI	70.15
Earnings Date	Aug 8, 2025

About Checkpoint Therapeutics

Manufacturing Integration Technology Ltd, an investment holding company, designs, develops, manufactures, and distributes automated equipment and components in China, Singapore, Europe, the United States, and rest of Asia. The company operates through Built-To-Print and Customised Automation segments. It offers contract equipment manufacturing services. The company also manufactures and repair of lifting and handling equipment; and manufactures industrial process control equipment. It serves semiconductor, solar, manufacturing systems, customiz...

• Industry: Special Industry Machinery, not elsewhere classified
• Founded: 1992
• Employees: 85
• Stock Exchange: Singapore Exchange
• Ticker Symbol: M11

Financial Performance

In 2024, SGX:M11's revenue was 6.66 million, a decrease of -20.37% compared to the previous year's 8.37 million. Losses were -3.46 million, 0.14% more than in 2023.